Latest Posts


CS.04: Advanced Cardiovascular Disease: Complications and Challenges
 
Douglas L. Mann
Washington University School of Medicine, Barnes Jewish Hospital
St. Louis, MO
 
A Multicenter, Randomized Study Assessing the Efficacy of Left Ventricular Augmentation with Algisyl-LVR in the Treatment of Advanced Heart Failure Patients with Ischemic and Non-ischemic Cardiomyopathy: Interim Results of the AUGMENT-HF Study 
 
 
Posted by Summer H. on Nov 20, 2013 3:33 PM CST

CS.04: Advanced Cardiovascular Disease: Complications and Challenges
 
Joerg Schwab
University of Bonn
Bonn, Germany
 
Dedicated ICD Programming Reduces the Number of Inappropriate Therapies in a Real World Primary Prevention ICD Population: The DECREASE - Trial
 
 
Posted by Summer H. on Nov 20, 2013 3:25 PM CST

CS.04: Advanced Cardiovascular Disease: Complications and Challenges
 
Jeffrey H. Lawson
Duke University
Durham, NC
 
First-in-Man Clinical Evaluation of a Novel Tissue Engineered Vascular Graft
 
 
Posted by Summer H. on Nov 20, 2013 3:10 PM CST

CS.04: Advanced Cardiovascular Disease: Complications and Challenges
 
Amy Sarma
Brigham and Women's Hospital 
Boston, MA
 
The Incidence of Kidney Injury for Patients Treated with Intensive versus Less Potent Statin Therapy after an Acute Coronary Syndrome
 
 
Posted by Summer H. on Nov 20, 2013 3:02 PM CST

CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis
 
Michael J. Koren
Jacksonville Center for Clinical Research
Jacksonville, FL
 
Randomized Comparison of the Safety, Tolerability, and Efficacy of Long-term Administration of AMG 145 versus Standard of Care in 1104 Patients: 52-week Results from the OSLER Study
 
 
Posted by Summer H. on Nov 20, 2013 1:23 PM CST

CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis
 
Arshed Ali Quyyumi
Emory University
Atlanta, GA
 
Effect of Angiotensin II Type I Receptor Blockade on Carotid Artery Atherosclerosis: A Randomized Trial Comparing Valsartan and Placebo (EFFERVESCENT) 
 
 
Posted by Summer H. on Nov 20, 2013 1:10 PM CST

CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis
 
Thomas J Wang
Vanderbilt University
Nashville, TN
 
Daylight: Vitamin D Therapy in Individuals at High Risk of Hypertension 
 
 
Posted by Summer H. on Nov 20, 2013 12:50 PM CST

CS.03: Novel Approaches to Treating Hypertension and Atherosclerosis
 
Tobias Bonten
Leiden University Medical Center
Leiden, Netherlands
 
Does Aspirin Intake at Bedtime Decrease Blood Pressure and Morning Peak of Platelet Reactivity?: A Randomized Cross-over Trial 
 
Presentation Slides | Summary Slide | Abstract | Presentation Audio | Discussant Audio
 
Posted by Summer H. on Nov 20, 2013 12:11 PM CST

CS.02: Biomarkers in Populations
 
Lijing L. Yan
The George Institute for Global Health at Peking University Health Science Center
Beijing, China
 
China Rural Health Initiative - Primary Care Provider Study: A Large Cluster-Randomized Controlled Trial of High Cardiovascular Risk Management in Rural China 
 
 
Posted by Summer H. on Nov 20, 2013 11:53 AM CST

CS.02: Biomarkers in Populations
 
Jack V. Tu
Institute for Clinical Evaluative Sciences
Toronto, ON, Canada
 
Ten-Year Incidence Rates of Major Cardiovascular Events in 697,690 Immigrants to Ontario, Canada, by Ethnic Group and Country of Birth
 
 
more...
Posted by Summer H. on Nov 20, 2013 11:34 AM CST
< Prev    1 2 3 4 5 6 7 8 9 ... 15